BRIDION Drug Patent Profile
✉ Email this page to a colleague
When do Bridion patents expire, and when can generic versions of Bridion launch?
Bridion is a drug marketed by Msd Sub Merck and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has forty-two patent family members in thirty countries.
The generic ingredient in BRIDION is sugammadex sodium. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sugammadex sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bridion
A generic version of BRIDION was approved as sugammadex sodium by ASPIRO on June 9th, 2023.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BRIDION?
- What are the global sales for BRIDION?
- What is Average Wholesale Price for BRIDION?
Summary for BRIDION
International Patents: | 42 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Clinical Trials: | 65 |
Patent Applications: | 208 |
Drug Prices: | Drug price information for BRIDION |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for BRIDION |
What excipients (inactive ingredients) are in BRIDION? | BRIDION excipients list |
DailyMed Link: | BRIDION at DailyMed |


Paragraph IV (Patent) Challenges for BRIDION
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
BRIDION | Injection | sugammadex sodium | 200 mg/2 mL and 500 mg/5 mL | 022225 | 14 | 2019-12-16 |
US Patents and Regulatory Information for BRIDION
BRIDION is protected by one US patents and two FDA Regulatory Exclusivities.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | AP | RX | Yes | No | RE44733*PED | ⤷ Try for Free | Y | ⤷ Try for Free | ||
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | AP | RX | Yes | Yes | RE44733*PED | ⤷ Try for Free | Y | ⤷ Try for Free | ||
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | AP | RX | Yes | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | AP | RX | Yes | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | AP | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | AP | RX | Yes | Yes | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BRIDION
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | 7,265,099 | ⤷ Try for Free |
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | 6,949,527 | ⤷ Try for Free |
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | 7,265,009 | ⤷ Try for Free |
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | 7,265,099 | ⤷ Try for Free |
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | 6,949,527 | ⤷ Try for Free |
Msd Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | 7,265,009 | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BRIDION
See the table below for patents covering BRIDION around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 1370073 | ⤷ Try for Free | |
Japan | 4563972 | ⤷ Try for Free | |
China | 1188428 | ⤷ Try for Free | |
World Intellectual Property Organization (WIPO) | 0140316 | ⤷ Try for Free | |
Norway | 328790 | ⤷ Try for Free | |
Australia | 7508900 | ⤷ Try for Free | |
South Africa | 200203538 | 6-mercapto-cyclodextrin derivatives; reversal agents for drug-induced neuromuscular block. | ⤷ Try for Free |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for BRIDION
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1259550 | 47/2008 | Austria | ⤷ Try for Free | PRODUCT NAME: SUGAMMADEX; 6-PER-DEOXY-6-PER-(2-CARBOXYETHYL) THIO-Y-CYCLODEXTRIN UND PHARMAZEUTISCH VERTRAEGLICHES SALZ HIERVON; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725 |
1259550 | SPC031/2008 | Ireland | ⤷ Try for Free | SPC031/2008: 20090428, EXPIRES: 20230724 |
1259550 | 122008000068 | Germany | ⤷ Try for Free | PRODUCT NAME: SUGAMMADEX ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725 |
1259550 | 2008C/047 | Belgium | ⤷ Try for Free | PRODUCT NAME: SUGAMMADEX SODIQUE; AUTHORISATION NUMBER AND DATE: EU/1/08/466001 20080729 |
1259550 | CA 2009 00002 | Denmark | ⤷ Try for Free | PRODUCT NAME: SUGAMMADEX ELLER FARMACEUTISK AKTIVE SALTE ELLER ESTERE DERAF, HERUNDER SUGAMMADEXNATRIUM |
1259550 | 340 | Finland | ⤷ Try for Free | |
1259550 | SZ 47/2008 | Austria | ⤷ Try for Free | PRODUCT NAME: SUGAMMADEX; 6-PER-DEOXY-6-PER-(2-CARBOXYETHYL) THIO-Y-CYCLODEXTRIN UND PHARMAZEUTISCH VERTRÄGLICHES SALZ HIERVON |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for Bridion
More… ↓